Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Audrey D Zhang"'
Autor:
Anisa Rowhani-Farid, Mikas Grewal, Steven Solar, Allen O. Eghrari, Audrey D. Zhang, Cary P. Gross, Harlan M. Krumholz, Joseph S. Ross
Publikováno v:
Scientific Data, Vol 10, Iss 1, Pp 1-8 (2023)
Abstract The impact and effectiveness of clinical trial data sharing initiatives may differ depending on the data sharing model used. We characterized outcomes associated with models previously used by the U.S. National Institutes of Health (NIH): Na
Externí odkaz:
https://doaj.org/article/5f5e5f0509374313b1084dac24569394
Autor:
Anisa Rowhani-Farid, Kyungwan Hong, Mikas Grewal, Jesse Reynolds, Audrey D Zhang, Joshua D Wallach, Joseph S Ross
Publikováno v:
BMJ evidence-based medicine.
ObjectiveThis study examined the extent to which trials presented at major international medical conferences in 2016 consistently reported their study design, end points and results across conference abstracts, published article abstracts and press r
Publikováno v:
Journal of General Internal Medicine
Autor:
Audrey D. Zhang, Timothy S. Anderson
Publikováno v:
JAMA
This study uses Open Payments data to characterize and compare payments to physicians and advanced practice clinicians.
Autor:
Joseph S. Ross, Audrey D Zhang, Cary P. Gross, Anisa Rowhani-Farid, Alexander C Egilman, Harlan M. Krumholz
BackgroundThe impact and value of clinical trial data sharing, including the number and quality of publications that result from shared data – “shared data publications” – may differ depending on the data sharing model used.MethodsWe characte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c5bbaad591b50ea963529261e8cc46b3
https://doi.org/10.1101/2021.09.10.21263404
https://doi.org/10.1101/2021.09.10.21263404
Autor:
Nicholas S. Downing, Meera Dhodapkar, Nilay Shah, Jeremy Puthumana, Audrey D Zhang, Joseph S. Ross
Publikováno v:
JAMA Network Open
Key Points Question What is the strength of evidence supporting supplemental new indication approvals for drugs and biologics and how does it compare with the evidence that supported their original approval? Findings In this cross-sectional study of
Autor:
Mayur M. Desai, Holly K. Grossetta Nardini, Deanna Cheng, Kun Wang, Joshua D. Wallach, Harlan M. Krumholz, Audrey D Zhang, Michael B. Bracken, Joseph S. Ross, Haiqun Lin
Publikováno v:
The BMJ
Objectives To conduct a systematic review and meta-analysis of the effects of rosiglitazone treatment on cardiovascular risk and mortality using multiple data sources and varying analytical approaches with three aims in mind: to clarify uncertainties
Publikováno v:
Clin Trials
Background/Aims The US Food and Drug Administration outlines clinical studies as postmarketing requirements and commitments to be fulfilled following approval of new drugs and biologics (“therapeutics”). Regulators have increasingly emphasized li
Autor:
Audrey D Zhang, Joshua D. Wallach, Jennifer E. Miller, Michaela A. Dinan, Joseph S. Ross, Tanvee Varma, Joshua J. Skydel, Dominic Schnabel, Cary P. Gross
Publikováno v:
JAMA Network Open
This cross-sectional study investigates demographic data reporting and demographic representation by sex, age, and race/ethnicity in premarketing and postmarketing studies of novel cancer therapeutics.
Key Points Question Are the demographic cha
Key Points Question Are the demographic cha
Autor:
Alexander C Egilman, Joshua D. Wallach, Jeremy Puthumana, Joseph S. Ross, Audrey D Zhang, Jason L. Schwartz
Publikováno v:
Journal of General Internal Medicine